$3230 | SAVE $570 | Single User Excluding Section 10 (company profiles)
$4803 | SAVE $847 | Single User
$5653 | SAVE $997 | Multi User
$6928 | SAVE $1,222 | Corporate License
$8500 | SAVE $1,500 | Enterprise License

Insulin Delivery Devices Market by Type, Insulin Pumps, Pen Needles, Insulin Syringes and End User - Global Forecast to 2021

Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021
[Lowest Price Guaranteed: $3,230]

Published by MarketsandMarkets: 24 Apr 2017 | 51601 | In Stock
Related Topics: Diabetes , Lilly

Introduction

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021).

Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices are the major factors driving the growth of this market. However, needle anxiety, emergence of oral drug delivery methods, and the growing trend of reuse of pen needles and infusion sets are the major factors restraining the growth of this market. Furthermore, increasing research and development activities and increasing diabetes-related health expenditure in emerging countries are likely to offer significant growth opportunities for players operating in the market.

The global insulin delivery devices market is segmented on the basis of type, end user, and region. In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is projected to have the highest growth rate in the forecast period. Factors such as rising prevalence of diabetes, high adoption of insulin pens, and government initiatives in Singapore are expected to support the growth of the Asia-Pacific insulin delivery devices market.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, joint ventures, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the insulin delivery devices market.

 By Company Type: Tier 1: 70%, Tier 2: 22%, Tier 3: 8%

 By Designation: Director Level: 65%, C-level: 25%, Others: 10%

 By Region: North America: 55%, Europe: 20%, APAC: 20%, RoW: 5%

Key players in the global insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.).


Research Coverage:

This report studies the insulin delivery devices market based on type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one, or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the types of insulin delivery devices offered by top players in the insulin delivery devices market

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the insulin delivery devices market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for insulin delivery devices across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the insulin delivery devices market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the insulin delivery devices market

Table of Contents
for Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021

  • TABLE OF CONTENTS

    1 INTRODUCTION 15

    1.1 OBJECTIVES OF THE STUDY 15

    1.2 MARKET DEFINITION 15

    1.3 MARKET SCOPE 16

    1.3.1 MARKETS COVERED 16

    1.3.2 YEARS CONSIDERED FOR THE STUDY 16

    1.4 CURRENCY 17

    1.5 LIMITATIONS 17

    1.6 STAKEHOLDERS 17

    2 RESEARCH METHODOLOGY 18

    2.1 RESEARCH METHODOLOGY STEPS 18

    2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19

    2.2.1 SECONDARY RESEARCH 19

    2.2.1.1 Key data from secondary sources 19

    2.2.2 PRIMARY RESEARCH 20

    2.2.2.1 Key data from primary sources 21

    2.2.2.2 Key insights from primary sources 21

    2.2.2.3 Key industry insights 22

    2.3 MARKET SIZE ESTIMATION METHODOLOGY 22

    2.4 MARKET DATA VALIDATION AND TRIANGULATION 25

    2.5 ASSUMPTIONS FOR THE STUDY 26

    3 EXECUTIVE SUMMARY 27

    4 PREMIUM INSIGHTS 30

    4.1 INSULIN DELIVERY DEVICES: MARKET SNAPSHOT 30

    4.2 GEOGRAPHIC ANALYSIS: INSULIN DELIVERY DEVICES MARKET, BY TYPE (2016) 31

    4.3 INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2016 VS. 2021 (USD BILLION) 32

    4.4 GEOGRAPHIC SNAPSHOT OF THE INSULIN DELIVERY DEVICES MARKET 32

    5 MARKET OVERVIEW 33

    5.1 INTRODUCTION 34

    5.2 MARKET DYNAMICS 34

    5.2.1 DRIVERS 35

    5.2.1.1 Growing diabetic population 35

    5.2.1.2 Technological advancements in insulin delivery devices 36

    5.2.1.3 Favorable reimbursement environment and government support in selected countries 37

    5.2.1.4 Conferences, Meetings, and Congresses to create awareness about Insulin delivery devices 37

    5.2.2 RESTRAINTS 39

    5.2.2.1 Poor reimbursement structure in developing countries 39

    5.2.2.2 Needle anxiety in patients to affect the growth of the pen needles and syringes market 39

    5.2.2.3 Oral insulin as an alternative drug delivery method 39

    5.2.2.4 Issues associated with the reuse of pen needles and infusion sets 40

    5.2.3 OPPORTUNITIES 40

    5.2.3.1 Increasing research and development activities 40

    5.2.3.2 Increasing diabetes-related health expenditure in emerging economies 40

    5.2.3.3 Safety needles 41

    5.2.4 CHALLENGE 41

    5.2.4.1 Severe shortage of endocrinologists in the U.S. 41

    6 INSULIN DELIVERY DEVICES MARKET, BY TYPE 42

    6.1 INTRODUCTION 43

    6.2 PENS 44

    6.2.1 REUSABLE INSULIN PENS 46

    6.2.2 DISPOSABLE INSULIN PENS 47

    6.3 INSULIN PUMPS 49

    6.3.1 EXTERNAL/TETHERED PUMPS 50

    6.3.2 PATCH PUMPS 52

    6.4 PEN NEEDLES 53

    6.4.1 STANDARD PEN NEEDLES 54

    6.4.2 SAFETY PEN NEEDLES 55

    6.5 INSULIN SYRINGES 57

    6.6 OTHER INSULIN DELIVERY DEVICES 58

    7 INSULIN DELIVERY DEVICES MARKET, BY END USER 60

    7.1 INTRODUCTION 61

    7.2 PATIENTS/HOMECARE 62

    7.3 HOSPITALS & CLINICS 63

    8 INSULIN DELIVERY DEVICES MARKET, BY REGION 65

    8.1 INTRODUCTION 66

    8.2 NORTH AMERICA 67

    8.2.1 U.S. 70

    8.2.1.1 Rising prevalence of diabetes and favorable reimbursement scenario 70

    8.2.1.2 Awareness activities to stimulate usage of insulin delivery devices in the U.S. 70

    8.2.1.3 Growing venture capital investments and issuance of IPOs 71

    8.2.1.4 FDA approvals to increase the commercial availability of insulin delivery devices 71

    8.2.2 CANADA 74

    8.2.2.1 High prevalence of diabetes and favorable reimbursement for insulin delivery devices 74

    8.2.2.2 Regulations for the usage of safety-engineered needles 74

    8.3 EUROPE 77

    8.3.1.1 EU’s directive on the prevention of sharps injuries in hospitals and the healthcare sector 78

    8.3.2 GERMANY 81

    8.3.2.1 High prevalence of diabetes, favorable reimbursement for insulin devices 81

    8.3.3 FRANCE 83

    8.3.3.1 High insurance coverage and increasing affordability 83

    8.3.3.2 Conferences and exhibitions 83

    8.3.4 U.K. 85

    8.3.4.1 Role of diabetes U.K. in research and diabetes care 85

    8.3.4.2 Low insulin pump penetration in the U.K. 86

    8.3.5 REST OF EUROPE (ROE) 88

    8.3.5.1 Spain: Regulations for mandatory use of safety needles, large diabetic population 88

    8.3.5.2 Italy: Regional variations in terms of coverage and benefits to hinder market growth 89

    8.3.5.3 Strong presence of major insulin delivery device manufacturers in ROE countries 89

    8.3.5.4 Large diabetic populations in Russia, Romania, Poland, and Portugal 90

    8.4 ASIA- PACIFIC 93

    8.4.1.1 High diabetes incidence and population in Asia-Pacific 94

    8.4.1.2 Partnerships among global and local players in Asia-Pacific 94

    8.4.1.3 Japan: High adoption of insulin pens and approval of injectable insulin 95

    8.4.1.4 India: Low penetration of pen needles & pumps and low awareness to restrain market growth 95

    8.4.1.5 Government initiatives in Singapore 95

    8.4.1.6 Vietnam, a potential market for insulin delivery devices 96

    8.4.1.7 Australia: Amendments in NDSS to broaden patient access to diabetes products 96

    8.5 ROW 99

    8.5.1.1 Increasing diabetic population 100

    8.5.1.2 Rising awareness on diabetes 100

    8.5.1.3 Conferences 100

    9 COMPETITIVE LANDSCAPE 103

    9.1 OVERVIEW 103

    9.2 MARKET SHARE ANALYSIS 104

    9.3 COMPETITIVE SITUATION AND TRENDS 109

    9.3.1 MARKETING AND PROMOTION 110

    9.3.2 AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS 110

    9.3.3 PRODUCT LAUNCHES 111

    9.3.4 EXPANSIONS 112

    9.3.5 OTHER STRATEGIES 113

    10 COMPANY PROFILES 114

    (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

    10.1 INTRODUCTION 114

    10.2 BECTON, DICKINSON AND COMPANY 115

    10.3 NOVO NORDISK A/S 118

    10.4 MEDTRONIC PLC 120

    10.5 SANOFI 122

    10.6 ELI LILLY AND COMPANY 124

    10.7 YPSOMED HOLDING AG 126

    10.8 ANIMAS CORPORATION (JOHNSON AND JOHNSON) 128

    10.9 TANDEM DIABETES CARE, INC. 130

    10.10 INSULET CORPORATION 132

    10.11 BIOCON LIMITED 134

    *Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

    11 APPENDIX 136

    11.1 DISCUSSION GUIDE 136

    11.2 OTHER DEVELOPMENTS 141

    11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 144

    11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 146

    11.5 AVAILABLE CUSTOMIZATIONS 147

    11.6 RELATED REPORTS 148

    11.7 AUTHOR DETAILS 149

List Of Tables
in Insulin Delivery Devices Market by Type, Insulin Pumps, Pen Needles, Insulin Syringes and End User - Global Forecast to 2021

LIST OF TABLES


TABLE 1 10 COUNTRIES/TERRITORIES WITH THE HIGHEST NUMBER OF DIABETICS

(20–79 YEARS), 2015 & 2040 35

TABLE 2 FDA APPROVALS IN THE INSULIN DELIVERY DEVICES MARKET (2014–2016) 37

TABLE 3 CONFERENCES, MEETINGS, AND CONGRESSES FOCUSING ON INSULIN DELIVERY DEVICES (2014–2017) 38

TABLE 4 GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 43

TABLE 5 GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014–2021 (THOUSAND UNITS) 43

TABLE 6 PENS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 45

TABLE 7 PENS MARKET SIZE, BY TYPE, 2014–2021 (THOUSAND UNITS) 45

TABLE 8 PENS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 45

TABLE 9 PENS MARKET SIZE, BY REGION, 2014–2021 (THOUSAND UNITS) 46

TABLE 10 REUSABLE INSULIN PENS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 46

TABLE 11 REUSABLE INSULIN PENS MARKET SIZE, BY REGION,

2014–2021 (THOUSAND UNITS) 47

TABLE 12 DISPOSABLE INSULIN PENS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 48

TABLE 13 DISPOSABLE INSULIN PENS MARKET SIZE, BY REGION,

2014–2021 (THOUSAND UNITS) 48

TABLE 14 INSULIN PUMPS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 49

TABLE 15 INSULIN PUMPS MARKET SIZE, BY TYPE, 2014–2021 (THOUSAND UNITS) 49

TABLE 16 INSULIN PUMPS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 50

TABLE 17 INSULIN PUMPS MARKET SIZE, BY REGION, 2014–2021 (THOUSAND UNITS) 50

TABLE 18 EXTERNAL/TETHERED PUMPS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 51

TABLE 19 EXTERNAL/TETHERED PUMPS MARKET SIZE, BY REGION,

2014–2021 (THOUSAND UNITS) 51

TABLE 20 PATCH PUMPS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 52

TABLE 21 PATCH PUMPS MARKET SIZE, BY REGION, 2014–2021 (THOUSAND UNITS) 52

TABLE 22 PEN NEEDLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 53

TABLE 23 PEN NEEDLES MARKET SIZE, BY TYPE, 2014–2021 (THOUSAND UNITS) 53

TABLE 24 PEN NEEDLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54

TABLE 25 PEN NEEDLES MARKET SIZE, BY REGION, 2014–2021 (THOUSAND UNITS) 54

TABLE 26 STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55

TABLE 27 STANDARD PEN NEEDLES MARKET SIZE, BY REGION,

2014–2021 (THOUSAND UNITS) 55

TABLE 28 SAFETY PEN NEEDLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 56

TABLE 29 SAFETY PEN NEEDLES MARKET SIZE, BY REGION, 2014–2021 (THOUSAND UNITS) 56

TABLE 30 INSULIN SYRINGES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57

TABLE 31 INSULIN SYRINGES MARKET SIZE, BY REGION, 2014–2021 (THOUSAND UNITS) 58


TABLE 32 OTHER INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 59

TABLE 33 OTHER INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION,

2014–2021 (THOUSAND UNITS) 59

TABLE 34 INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 61

TABLE 35 PATIENTS/HOMECARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 63

TABLE 36 HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 64

TABLE 37 INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 66

TABLE 38 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SIZE,

BY COUNTRY, 2014-2021 (USD MILLION) 68

TABLE 39 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SIZE,

BY TYPE, 2014-2021 (USD MILLION) 68

TABLE 40 NORTH AMERICA: INSULIN PENS MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 68

TABLE 41 NORTH AMERICA: INSULIN PUMPS MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 69

TABLE 42 NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 69

TABLE 43 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SIZE,

BY END USER, 2014-2021 (USD MILLION) 69

TABLE 44 INVESTEMENTS MADE BY COMPANIES FOR DIABETES MANAGEMENT, 2015 71

TABLE 45 FDA APPROVALS FOR INSULIN DELIVERY DEVICES (2013-2016) 72

TABLE 46 U.S.: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 72

TABLE 47 U.S.: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 72

TABLE 48 U.S.: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 73

TABLE 49 U.S.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 73

TABLE 50 U.S.: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 73

TABLE 51 ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES IN CANADA FOR TYPE I DIABETES, MARCH 2015 74

TABLE 52 CANADA: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 75

TABLE 53 CANADA: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 75

TABLE 54 CANADA: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 75

TABLE 55 CANADA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 76

TABLE 56 CANADA: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 76

TABLE 57 EUROPE: INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 78

TABLE 58 EUROPE: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 78

TABLE 59 EUROPE: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 79

TABLE 60 EUROPE: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 79

TABLE 61 EUROPE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 80


TABLE 62 EUROPE: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 80

TABLE 63 GERMANY: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 81

TABLE 64 GERMANY: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 81

TABLE 65 GERMANY: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 82

TABLE 66 GERMANY: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 82

TABLE 67 GERMANY: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 82

TABLE 68 FRANCE: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 84

TABLE 69 FRANCE: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 84

TABLE 70 FRANCE: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 84

TABLE 71 FRANCE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 85

TABLE 72 FRANCE: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 85

TABLE 73 U.K.: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 87

TABLE 74 U.K.: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 87

TABLE 75 U.K.: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 87

TABLE 76 U.K.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 88

TABLE 77 U.K.: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 88

TABLE 78 INDICATIVE LIST: COMPANIES HEADQUARTERED IN ROE COUNTRIES 89

TABLE 79 ROE: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 90

TABLE 80 ROE: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 91

TABLE 81 ROE: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 91

TABLE 82 ROE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 91

TABLE 83 ROE: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 92

TABLE 84 DIABETES PREVALENCE IN ASIA-PACIFIC, BY COUNTRY 94

TABLE 85 ASIA-PACIFIC: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 97

TABLE 86 ASIA-PACIFIC: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 97

TABLE 87 ASIA-PACIFIC: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 97

TABLE 88 ASIA-PACIFIC: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 98

TABLE 89 ASIA-PACIFIC: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 98

TABLE 90 CONFERENCE IN AFRICA, BRAZIL, AND THE MIDDLE EAST (2015-2017) 100

TABLE 91 ROW: INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 101

TABLE 92 ROW: INSULIN PENS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 101

TABLE 93 ROW: INSULIN PUMPS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 102

TABLE 94 ROW: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 102

TABLE 95 ROW: INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 102


TABLE 96 MARKETING AND PROMOTION: RECENT DEVELOPMENTS (2014–2017) 110

TABLE 97 AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS: RECENT DEVELOPMENTS (2014–2017) 110

TABLE 98 PRODUCT LAUNCHES: RECENT DEVELOPMENTS (2014–2017) 111

TABLE 99 EXPANSIONS: RECENT DEVELOPMENTS (2014–2017) 112

TABLE 100 OTHER STRATEGIES: RECENT DEVELOPMENTS (2014–2017) 113

List Of Figures, Charts and Diagrams
in Insulin Delivery Devices Market by Type, Insulin Pumps, Pen Needles, Insulin Syringes and End User - Global Forecast to 2021

LIST OF FIGURES


FIGURE 1 GLOBAL INSULIN DELIVERY DEVICES MARKET: RESEARCH METHODOLOGY STEPS 18

FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 23

FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23

FIGURE 4 RESEARCH DESIGN 24

FIGURE 5 DATA TRIANGULATION METHODOLOGY 25

FIGURE 6 INSULIN PENS SEGMENT COMMANDED THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES MARKET IN 2016 27

FIGURE 7 PATIENTS/HOMECARE SEGMENT TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 28

FIGURE 8 NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES MARKET IN 2016 29

FIGURE 9 ASIA-PACIFIC OFFERS SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN THE INSULIN DELIVERY DEVICES MARKET 30

FIGURE 10 INSULIN PENS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2016 31

FIGURE 11 PATIENTS/HOMECARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES MARKET IN 2016 32

FIGURE 12 ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD (2016–2021) 32

FIGURE 13 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34

FIGURE 14 PENS COMMANDED THE LARGEST SHARE IN INSULIN DELIVERY DEVICES MARKET IN 2016 44

FIGURE 15 PATIENTS/HOMECARE SEGMENT TO COMMAND THE LARGEST SHARE OF THE INSULIN DELIVERY DEVICES END-USER MARKET 61

FIGURE 16 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT 67

FIGURE 17 EUROPE: INSULIN DELIVERY DEVICES MARKET SNAPSHOT 77

FIGURE 18 DIABETES U.K.: FUNDS RAISED VS. FUNDS INVESTED 86

FIGURE 19 COMPARISON OF DIABETES CASES, RELATED DEATHS IN EUROPEAN

COUNTRIES, 2015 90

FIGURE 20 ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SNAPSHOT 93

FIGURE 21 ROW INSULIN DELIVERY DEVICES MARKET SNAPSHOT 99

FIGURE 22 GROWTH STRATEGIES, BY COMPANY 103

FIGURE 23 MARKET SHARE ANALYSIS FOR INSULIN PENS, BY KEY PLAYER, 2016 104

FIGURE 24 MARKET SHARE ANALYSIS FOR INSULIN PUMPS, BY KEY PLAYER, 2016 104

FIGURE 25 MARKET SHARE ANALYSIS FOR PEN NEEDLES, BY KEY PLAYER, 2016 105

FIGURE 26 MARKET SHARE ANALYSIS FOR SYRINGES, BY KEY PLAYER, 2016 105

FIGURE 27 COMPANIES ADOPTED MARKETING & PROMOTION AS KEY GROWTH STRATEGY FROM 2013 TO 2016 109

FIGURE 28 GEOGRAPHIC ASSESSMENT OF PLAYERS IN THE INSULIN DELIVERY DEVICES MARKET 114

FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016) 115

FIGURE 30 NOVO NORDISK A/S: COMPANY SNAPSHOT (2016) 118

FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT (2016) 120

FIGURE 32 SANOFI: COMPANY SNAPSHOT (2016) 122

FIGURE 33 ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2015) 124

FIGURE 34 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2015) 126

FIGURE 35 JOHNSON AND JOHNSON: COMPANY SNAPSHOT (2016) 128

FIGURE 36 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2015) 130

FIGURE 37 INSULET CORPORATION: COMPANY SNAPSHOT (2015) 132

FIGURE 38 BIOCON, LTD.: COMPANY SNAPSHOT (2015) 134

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

51601 | MD 5192

Number of Pages

151

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Latin America Infusion Pump Market by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), Setting (Hospital, Ambulatory Centers), Accessories - Forecast to 2021
The Latin American infusion pumps and accessories market is estimated to reach USD 671.9 million by ...
20 Sep 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Insulin Pumps - Medical Devices Pipeline Assessment, 2016
Insulin Pumps - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devices sector ...
09 May 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Insulin Pens - Medical Devices Pipeline Assessment, 2016
Insulin Pens - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devices sector r...
01 May 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Disposable Insulin Pumps - Medical Devices Pipeline Assessment, 2016
Disposable Insulin Pumps - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devi...
01 Apr 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Infusion Pump Market - by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), by Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), by End User (Hospital, Home Care, Ambulatory Surgery Centers) - Global Forecast to 2020
The global infusion pumps and accessories market is expected to grow at a CAGR of 5.8% during the fo...
11 Jan 2016 by MarketsandMarkets USD $3,953 (normally
USD $4,651)
More Info
SAVE 15% today! Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020
The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8...
04 Jan 2016 by MarketsandMarkets USD $3,953 (normally
USD $4,651)
More Info
SAVE 15% today! Physician Views: The return of inhaled insulin – a paradigm shift or hard sell?
Scope Sanofi is currently in the process of launching Afrezza in the US market. Afrezza is an inhale...
13 Feb 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: What opportunity for biosimilar basal insulin?
Scope Two weeks ago, Sanofi significantly downgraded internal revenue projections for Lantus, its lo...
12 Nov 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: As MannKind's Afrezza nears approval, what opportunity for an inhaled insulin?
Scope MannKind's confirmation that the FDA has extended the PDUFA date for its inhaled insulin Afrez...
10 Apr 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views – Sanofi's no-go decision on lixisenatide monotherapy sharpens focus on GLP-1/insulin combination products – what are the expectations of GPs, endocrinologists based in the US, 5EU?
ScopeA key dynamic of the highly competitive diabetes market is the relatively limited differentiati...
01 Sep 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...